Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Open accessAbstract
Apolipoprotein E (apoE) is important in modulating the catabolism of remnants of triglyceride-rich lipoprotein particles. It is a polymorphic protein with the three common alleles coding for apoE2, apoE3, and apoE4. ApoE3 is considered the normal isoform, while apoE4 is associated both with hypercholesterolemia and type V hyperlipoproteinemia. We quantitated the kinetics of metabolism of apoE4 in 19 normolipidemic apoE3 homozygotes and 1 normolipidemic apoE4 homozygote, and compared this with the metabolism of apoE3 in 12 normolipidemic apoE3 homozygotes. In the apoE3 homozygous subjects, apoE4 was catabolized twice as fast as apoE3, with a mean plasma residence time of 0.37 +/- 0.01 d (+/- SEM) and 0.73 +/- 0.05 (P less than 0.001), respectively. When plasma was fractionated into the lipoprotein subclasses, the greatest amount of labeled apoE4 was present on very low density lipoproteins, while the largest fraction of labeled apoE3 was associated with high density lipoproteins. The plasma apoE concentration was decreased in an apoE4 homozygote compared with the apoE3 homozygotes (3.11 mg/dl vs. 4.83 +/- 0.35 mg/dl). The reduced apoE4 concentration was entirely due to a decreased apoE4 residence time in the apoE4 homozygote (0.36 d vs. 0.73 +/- 0.05 d for apoE3 in apoE3 homozygotes). These results indicate that apoE4 is kinetically different than apoE3, and suggest that the presence of apoE4 in hypercholesterolemic and type V hyperlipoproteinemic individuals may play an important pathophysiological role in the development of these dyslipoproteinemias.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In humans and animal models, apoE genotype is correlated with apoE protein levels in plasma, with ε2 showing the highest protein levels and ε4 the lowest.
“In humans and animal models, apoE genotype is correlated with apoE protein levels in plasma, with 2 showing the highest protein levels and 4 the lowest (Eto et al., 1986;Gregg et al., 1986;Raffai et al., 2001) (Fig. 2).”
From Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels (2008) · cites this paper as Gregg et al., 1986
The Abstract (p. 1) reports lower plasma apoE concentration in a human apoE4 homozygote than in apoE3 homozygotes, and the Discussion (p. 5) notes similarly low levels in three other apoE4 individuals. The paper does not establish that apoE2 has the highest plasma protein level or report plasma-level comparisons in animal models. (LLM, conf=0.89)
Experimental — accuracy not yet measuredIn peripheral blood, ApoE4 is catabolized twice as fast as ApoE3.
“where ApoE4 is catabolized twice as fast as ApoE3 [15].”
From In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS (2012) · cites this paper as [15]
ApoE3 shows preference for HDL particles, whereas apoE4 shows preference for VLDL particles.
“Despite near-normal receptor affinity of apoE4 the amino acid change leads to differences in distribution in lipoprotein classes: apoE3 shows preference for high density lipoprotein (HDL) particles, whereas apoE4 shows preference for very low density lipoprotein (VLDL) particles [38].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,756 · see citing works
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,171 · see citing works
Lipid Research Clinics Program
Renfrew, R. A. (1984) · JAMA · doi:10.1001/jama.1984.03350180015009 · Cited by 829 · see citing works
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 755 · see citing works
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741 · see citing works
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673 · see citing works
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563 · see citing works
Polymorphism of apolipoprotein E
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M. T. I. W. S.-V., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 408 · see citing works
Utermann, G., Jaeschke, M., & Menzel, J. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)81125-2 · Cited by 337 · see citing works
Packard, C. J., Munro, A. F., Lorimer, A. R., Gotto, A. M., & Shepherd, J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111644 · Cited by 298 · see citing works
Berman, M. D., Hall, M., Levy, R. I., Eisenberg, S., Bilheimer, D. W., Phair, R. D., & Goebel, R. H. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41575-5 · Cited by 243 · see citing works
Apolipoprotein E phenotypes and hyperlipidemia
Utermann, G., Kindermann, I., Kaffarnik, H., & Steinmetz, A. (1984) · Human Genetics · doi:10.1007/bf00286508 · Cited by 238 · see citing works
Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment
BREWER, H. B., ZECH, L. A., GREGG, R. E., SCHWARTZ, D., & SCHAEFER, E. J. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-623 · Cited by 226 · see citing works
Self-citationWeisgraber, K. H., & Mahley, R. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34612-4 · Cited by 212 · see citing works
Type III Hyperlipoproteinemia: Defective Metabolism of an Abnormal Apolipoprotein E
Gregg, R. E., Zech, L. A., Schaefer, E. J., & Brewer, H. B. (1981) · Science · doi:10.1126/science.7455696 · Cited by 180 · see citing works
Self-citationBouthillier, D., Sing, C. F., & Davignon, J. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37920-7 · Cited by 176 · see citing works
Olaisen, B., Teisberg, P., & Gedde‐Dahl, T. (1982) · Human Genetics · doi:10.1007/bf00333526 · Cited by 161 · see citing works
Francke, U., Brown, M. S., & Goldstein, J. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2826 · Cited by 137 · see citing works
Ehnholm, C., Mahley, R. W., Chappell, D. A., Weisgraber, K. H., Ludwig, E. H., & Witztum, J. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5566 · Cited by 137 · see citing works
Apolipoprotein E polymorphism and hyperlipidemia.
Assmann, G., Schmitz, G., Menzel, H. J., & Schulte, H. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.5.641 · Cited by 135 · see citing works
Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.
Ghiselli, G., Schaefer, E. J., Zech, L. A., Gregg, R. E., & Brewer, H. B. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110638 · Cited by 108 · see citing works
Self-citationApolipoprotein E metabolism in normolipoproteinemic human subjects.
Gregg, R., Zech, L., Schaefer, E., & Brewer, H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34460-6 · Cited by 90 · see citing works
Self-citationRetro-endocytosis of low density lipoprotein by cultured bovine aortic smooth muscle cells
Aulinskas, T. H., van der Westhuyzen, D. R., Bierman, E. L., Gevers, W., & Coetzee, G. A. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90048-5 · Cited by 66 · see citing works
Chromosomal localization of the human apoprotein ci gene and of a polymorphic apoprotein AII gene
Knott, T. J., Eddy, R. L., Robertson, M. E., Priestley, L. M., Scott, J., & Shows, T. B. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80368-x · Cited by 53 · see citing works
Chung, B. H., & Segrest, J. P. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37898-6 · Cited by 40 · see citing works
Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia
TURNER, P. R., Cortese, C., Wootton, R., Marenah, C. B., Miller, N. E., & Lewis, B. (1985) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1985.tb00152.x · Cited by 28 · see citing works
The localization of the gene for apolipoprotein C-II to chromosome 19
Fojo, S. S., Law, S. W. T., Brewer, H. B., Sakaguchi, A. Y., & Naylor, S. L. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80088-1 · Cited by 27 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [13]13. Gregg, R. E., D. Wilson, E. Rubalcaba, R. Ronan, and H. B. Brewer, Jr. 1983. Immunoquantitation of apolipoprotein E. Proc. Workshop Apolipoprotein Quantitation. 383–401.
Cited by
Sorted by citations
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981 · see citing works
Self-citationApolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836 · see citing works
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871 · see citing works
Self-citationApolipoprotein E: from cardiovascular disease to neurodegenerative disorders
Mahley, R. W. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1427-y · Cited by 837 · see citing works
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830 · see citing works
Three-Dimensional Structure of the LDL Receptor-Binding Domain of Human Apolipoprotein E
Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., & Agard, D. A. (1991) · Science · doi:10.1126/science.2063194 · Cited by 678 · see citing works
Hallman, D. M., Boerwinkle, E., Saha, N., Sandholzer, C., Menzel, H., Csazar, A., & Utermann, G. (1991) · PubMed · Cited by 511 · see citing works
Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y., Pericak-Vance, M., Schmechel, D., & Roses, A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11183 · Cited by 474 · see citing works
Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.
Dallongeville, J., Lussier‐Cacan, S., & Davignon, J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41611-6 · Cited by 444 · see citing works
Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113243 · Cited by 418 · see citing works
Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.
Kesäniemi, Y. A., Ehnholm, C., & Miettinen, T. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113107 · Cited by 402 · see citing works
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.
Linton, M. F., Gish, R., Hubl, S. T., Bütler, E., Esquivel, C., Bry, W. I., Boyles, J. K., Wardell, M. R., & Young, S. G. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115288 · Cited by 367 · see citing works
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
Riddell, D. R., Zhou, H., Atchison, K., Warwick, H. K., Atkinson, P. J., Jefferson, J., Xu, L., Aschmies, S., Kirksey, Y., Hu, Y., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1972-08.2008 · Cited by 342 · see citing works
Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H., & Lansbury, P. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.763 · Cited by 333 · see citing works
Apo E structure determines VLDL clearance and atherosclerosis risk in mice
Knouff, C., Hinsdale, M. E., Mezdour, H., Altenburg, M. K., Watanabe, M., Quarfordt, S. H., Sullivan, P. M., & Maeda, N. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6172 · Cited by 324 · see citing works
Amyloid β-Peptide Is Transported on Lipoproteins and Albumin in Human Plasma
Biere, A. L., Ostaszewski, B., Stimson, E. R., Hyman, B. T., Maggio, J. E., & Selkoe, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32916 · Cited by 331 · see citing works
Human apolipoprotein E: the Alzheimer's disease connection
Weisgraber, K. H., & Mahley, R. W. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.13.8940294 · Cited by 327 · see citing works
Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., & Agard, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31797-0 · Cited by 320 · see citing works
Apolipoprotein E: From lipid transport to neurobiology
Hauser, P. S., Narayanaswami, V., & Ryan, R. O. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.09.001 · Cited by 320 · see citing works
Human Apolipoprotein E4 Domain Interaction
Dong, L.-M., & Weisgraber, K. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19053 · Cited by 318 · see citing works
Morrow, J. A., Segall, M. L., Lund-Katz, S., Phillips, M. C., Knapp, M., Rupp, B., & Weisgraber, K. H. (2000) · Biochemistry · doi:10.1021/bi000099m · Cited by 315 · see citing works
Weisgraber, K. H. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42621-5 · Cited by 304 · see citing works
Kraft, H. G., Menzel, H., Hoppichler, F., Vogel, W., & Utermann, G. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113849 · Cited by 263 · see citing works
Modulation of Secreted β-Amyloid Precursor Protein and Amyloid β-Peptide in Brain by Cholesterol
Howland, D., Trusko, S. P., Savage, M. J., Reaume, A. G., Lang, D. M., Hirsch, J. D., Maeda, N., Siman, R., Greenberg, B., Scott, R. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16576 · Cited by 254 · see citing works
Eichner, J. E., Kuller, L. H., Orchard, T. J., Grandits, G. A., McCallum, L. M., Ferrell, R. E., & Neaton, J. D. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90732-r · Cited by 247 · see citing works
Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease?
Sparks, D. L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48466.x · Cited by 244 · see citing works
Huang, Y., Weisgraber, K. H., Mucke, L., & Mahley, R. W. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:189 · Cited by 242 · see citing works
Ordovas, J. M., Litwack-Klein, L., Wilson, P. W., Schaefer, M. M., & Schaefer, E. J. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38690-9 · Cited by 238 · see citing works
Self-citationThe key role of apolipoprotein E in atherosclerosis
Greenow, K. R., Pearce, N. J., & Ramji, D. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0631-3 · Cited by 236 · see citing works
Genetic factors affecting blood lipoproteins: the candidate gene approach.
Lusis, A. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38516-3 · Cited by 219 · see citing works
ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype
Minihane, A. M., Khan, S., Leigh-Firbank, E. C., Talmud, P., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1990 · Cited by 215 · see citing works
Bertrand, P., Poirier, J., Oda, T., Finch, C. E., & Pasinetti, G. M. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00097-c · Cited by 210 · see citing works
Apolipoprotein E and atherosclerosis: insight from animal and human studies
Davignon, J., Cohn, J. S., Mabile, L., & Bernier, L. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00097-2 · Cited by 208 · see citing works
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
Cruchaga, C., Kauwe, J. S. K., Nowotny, P., Bales, K., Pickering, E. H., Mayo, K., Bertelsen, S., Hinrichs, A., Fagan, A. M., Holtzman, D. M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds296 · Cited by 207 · see citing works
Schaefer, E. J., Lamon‐Fava, S., Johnson, S., Ordovás, J. M., Schaefer, M. M., Castelli, W. P., & Wilson, P. W. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1105 · Cited by 198 · see citing works
Self-citationIntroduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E
Raffaı̈, R. L., Dong, L., Farese, R. V., & Weisgraber, K. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201279298 · Cited by 192 · see citing works
Tudorache, I. F., Trusca, V. G., & Gafencu, A. V. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2017.05.003 · Cited by 186 · see citing works
Miettinen, T. A., Gylling, H., Vanhanen, H. T., & Ollus, A. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.9.1044 · Cited by 171 · see citing works
Martínez-Morillo, E., Hansson, O., Atagi, Y., Bu, G., Minthon, L., Diamandis, E. P., & Nielsen, H. M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1266-2 · Cited by 168 · see citing works
Ordovás, J. M., López‐Miranda, J., Pérez‐Jiménez, F., Rodríguez, C., Park, J.-S., Cole, T. G., & Schaefer, E. J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05439-p · Cited by 168 · see citing works
Self-citationApolipoprotein E and cholesterol in aging and disease in the brain
de Chaves, E. P., Narayanaswami, V., Christoffersen, C., & Nielsen, L. B. (2008) · Future Lipidology · doi:10.2217/17460875.3.5.505 · Cited by 164 · see citing works
Apolipoprotein E4 Alters Astrocyte Fatty Acid Metabolism and Lipid Droplet Formation
Farmer, B., Kluemper, J., & Johnson, L. (2019) · Cells · doi:10.3390/cells8020182 · Cited by 164 · see citing works
Kuusi, T., Nieminen, M. S., Ehnholm, C., Yki‐Järvinen, H., Valle, M., Nikkilä, E. A., & Taskinen, M. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.2.237 · Cited by 159 · see citing works
Molecular basis of exchangeable apolipoprotein function
Narayanaswami, V., & Ryan, R. O. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00176-6 · Cited by 152 · see citing works
ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain.
Bandaru, V. R., Troncoso, J., Wheeler, D., Pletnikova, O., Wang, J., Conant, K., & Haughey, N. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.024 · Cited by 157 · see citing works
The role of apolipoprotein E genetic variants in lipoprotein disorders.
RALL, S. C., & MAHLEY, R. W. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb01254.x · Cited by 150 · see citing works
Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging
Gupta, V. B., Laws, S. M., Villemagne, V. L., Ames, D., Bush, A. I., Ellis, K. A., Lui, J. K., Masters, C., Rowe, C. C., Szoeke, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318211c352 · Cited by 149 · see citing works
Beyond the CNS: The many peripheral roles of APOE
Martínez-Martínez, A. B., Torres-Perez, E., Devanney, N., Del Moral, R., Johnson, L. A., & Arbones-Mainar, J. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104809 · Cited by 149 · see citing works
Shimano, H., Yamada, N., Katsuki, M., Shimada, M., Gotoda, T., Harada, K., Murase, T., Fukazawa, C., Takaku, F., & Yazaki, Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1750 · Cited by 143 · see citing works
Bagger, Y. Z., Rasmussen, H. B., Alexandersen, P., Werge, T. M., Christiansen, C., Tankó, L. B., & PERF study group (2006) · Osteoporosis International · doi:10.1007/s00198-006-0255-2 · Cited by 140 · see citing works
Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation
Heeren, J., Grewal, T., Laatsch, A., Becker, N., Rinninger, F., Rye, K.-A., & Beisiegel, U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409324200 · Cited by 139 · see citing works
Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
Mills, S., Mallmann, J., Santacruz, A. M., Fuqua, A., Carril, M. M. G., Aisen, P. S., Althage, M. C., Belyew, S., Benzinger, T. L. S., Brooks, W. S., et al. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.017 · Cited by 139 · see citing works
Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis.
Heeren, J., Beisiegel, U., & Grewal, T. (2005) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000201282.64751.47 · Cited by 134 · see citing works
Smit, M., de Knijff, P., Rosseneu, M., Bury, J., Klasen, E., Frants, R., & Havekes, L. (1988) · Human Genetics · doi:10.1007/bf01790099 · Cited by 127 · see citing works
Rasmussen, K. L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.037 · Cited by 125 · see citing works
ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation
Minihane, A. M., Jofre‐Monseny, L., Olano-Martin, E., & Rimbach, G. H. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005435 · Cited by 125 · see citing works
APO E gene and gene-environment effects on plasma lipoprotein-lipid levels
HAGBERG, J. M., WILUND, K. R., & FERRELL, R. E. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.4.2.101 · Cited by 118 · see citing works
Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins.
Steinmetz, A., Jakobs, C., Motzny, S., & Kaffarnik, H. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.3.405 · Cited by 116 · see citing works
Seeding of Aβ Fibril Formation Is Inhibited by All Three Isotypes of Apolipoprotein E
Wood, S. J., Chan, W., & Wetzel, R. B. (1996) · Biochemistry · doi:10.1021/bi961074j · Cited by 115 · see citing works
Carmena, R., Roederer, G. O., Mailloux, H., Lussier‐Cacan, S., & Davignon, J. (1993) · Metabolism · doi:10.1016/0026-0495(93)90066-w · Cited by 117 · see citing works
Martin, L., Connelly, P. W., Nancoo, D., Wood, N., Zhang, Z.-J., Maguire, G. F., Quinet, E. M., Tall, A. R., Marcel, Y. L., & McPherson, R. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40735-7 · Cited by 113 · see citing works
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
Batal, R., Tremblay, M., Barrett, P. H. R., Jacques, H., Fredenrich, A., Mamer, O., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32379-8 · Cited by 113 · see citing works
Reduced levels of human apoE4 protein in an animal model of cognitive impairment
Sullivan, P. M., Han, B., Liu, F., Mace, B. E., Ervin, J. F., Wu, S., Koger, D., Paul, S., & Bales, K. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.011 · Cited by 113 · see citing works
Tsukamoto, K., Tangirala, R. K., Chun, S. H., Puré, E., & Rader, D. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.9.2162 · Cited by 108 · see citing works
Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
Ma, J., Brewer, H. B., & Potter, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00112-1 · Cited by 108 · see citing works
Self-citationKamboh, M. I. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05409-c · Cited by 104 · see citing works
Loane, E., Nolan, J. M., O’Donovan, Ó., Bhosale, P., Bernstein, P. S., & Beatty, S. (2008) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2007.10.008 · Cited by 105 · see citing works
Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis.
de Andrade, M., Thandi, I., Brown, S., Gotto, A. M., Patsch, W., & Boerwinkle, E. (1995) · PubMed Central · Cited by 103 · see citing works
Weisgraber, K. H., & Shinto, L. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99060-5 · Cited by 104 · see citing works
Kamboh, M. I., Ferrell, R. E., & Kottke, B. A. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38431-5 · Cited by 103 · see citing works
Impact of Apolipoprotein E on Alzheimer’s Disease
Hauser, P. S., & Ryan, R. O. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990156 · Cited by 101 · see citing works
Kokubo, Y., Chowdhury, A. H., Date, C., Yokoyama, A., Sobue, H., & Tanaka, H. (2000) · Stroke · doi:10.1161/01.str.31.6.1299 · Cited by 103 · see citing works
Apolipoprotein E Isoform Phenotype and LDL Subclass Response to a Reduced-Fat Diet
Dreon, D. M., Fernstrom, H. A., Miller, B., & Krauss, R. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.105 · Cited by 100 · see citing works
de Knijff, P., van den Maagdenberg, A. M., Stalenhoef, A. F., Leuven, J. A., Demacker, P. N., Kuyt, L. P., Frants, R. R., & Havekes, L. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115349 · Cited by 100 · see citing works
Zhang, H., Wu, J., & Zhu, J. (2010) · Journal of Immunology Research · doi:10.1155/2010/186813 · Cited by 98 · see citing works
Bergeron, N., & Havel, R. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118408 · Cited by 98 · see citing works
Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice
Hamanaka, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.353 · Cited by 96 · see citing works
ApoE genotype: from geographic distribution to function and responsiveness to dietary factors
Egert, S., Rimbach, G. H., & Huebbe, P. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000249 · Cited by 95 · see citing works
Couture, P., Brun, L., Szöts, F., Lelièvre, M., Gaudet, D., Després, J., Simard, J., Lupien, P. J., & Gagné, C. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.6.1007 · Cited by 94 · see citing works
Tsukamoto, K., Smith, P., Glick, J. M., & Rader, D. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119501 · Cited by 92 · see citing works
Functional Characterization of Apolipoprotein E Isoforms Overexpressed in Escherichia coli
Morrow, J. A., Arnold, K. S., & Weisgraber, K. H. (1999) · Protein Expression and Purification · doi:10.1006/prep.1999.1069 · Cited by 94 · see citing works
Jendresen, C., Årskog, V., Daws, M. R., & Nilsson, L. N. G. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0835-4 · Cited by 94 · see citing works
Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians.
Davignon, J., Bouthillier, D., Nestruck, A. C., & Sing, C. F. (1988) · PubMed Central · Cited by 92 · see citing works
Eto, M., Saito, M., Okada, M., Kume, Y., Kawasaki, F., Matsuda, M., Yoneda, M., Matsuki, M., Takigami, S., & Kaku, K. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34502 · Cited by 90 · see citing works
Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.
Russo, C., Angelini, G., Dapino, D., Piccini, A., Piombo, G., Schettini, G., Chen, S. G., Teller, J., Zaccheo, D., Gambetti, P., et al. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.26.15598 · Cited by 94 · see citing works
Genetic basis of lipoprotein disorders.
Breslow, J. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114176 · Cited by 90 · see citing works
Effect of Domain Interaction on Apolipoprotein E Levels in Mouse Brain
Ramaswamy, G., Xu, Q., Huang, Y., & Weisgraber, K. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1922-05.2005 · Cited by 87 · see citing works
ALTERATIONS IN APOLIPOPROTEIN E EXPRESSION DURING AGING AND NEURODEGENERATION
Masliah, E., Mallory, M. E., Veinbergs, I., Miller, A. L., & Samuel, W. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00038-x · Cited by 87 · see citing works
Chouinard‐Watkins, R., Rioux‐Perreault, C., Fortier, M., Tremblay‐Mercier, J., Zhang, Y., Lawrence, P., Vohl, M., Perron, P., Lorrain, D., Brenna, J. T., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513001268 · Cited by 86 · see citing works
Free radical theory of aging: Alzheimer’s disease pathogenesis
Harman, D. (1995) · AGE · doi:10.1007/bf02436085 · Cited by 86 · see citing works
Isoform- and cell-state-specific lipidation of ApoE in astrocytes
Lindner, K., Beckenbauer, K., van Ek, L. C., Titeca, K., de Leeuw, S. M., Awwad, K., Hanke, F., Korepanova, A. V., Rybin, V., van der Kam, E. L., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110435 · Cited by 84 · see citing works
Rall, S. C., Newhouse, Y. M., Clarke, H. R., Weisgraber, K. H., McCarthy, B. J., Mahley, R. W., & Bersot, T. P. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113988 · Cited by 103 · see citing works
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases
Xu, P., Li, D.-B., Tang, X., Bao, X., Huang, J., Tang, Y.-P., Yang, Y., Xu, H., & Fan, X.-T. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8461-3 · Cited by 84 · see citing works
Apolipoprotein E, Synaptic Plasticity and Alzheimer's Disease
Poirier, J., Minnich, A., & Davignon, J. (1995) · Annals of Medicine · doi:10.3109/07853899509019253 · Cited by 82 · see citing works
Acharya, P., Segall, M. L., Zaiou, M., Morrow, J., Weisgraber, K. H., Phillips, M. C., Lund-Katz, S., & Snow, J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00263-9 · Cited by 82 · see citing works
Corbo, R. M., Scacchi, R., Mureddu, L., Mulas, G., & ALFANO, G. (1995) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1995.tb00741.x · Cited by 80 · see citing works
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
Zannis, V. I., Kardassis, D., & Zanni, E. E. (1993) · Advances in Human Genetics 21 · doi:10.1007/978-1-4615-3010-7_3 · Cited by 78 · see citing works
Nikkilä, M. T., Solakivi, T., Lehtimäki, T. J., Koivula, T. A., Laippala, P., & Aström, B. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90120-1 · Cited by 78 · see citing works
Kamboh, M. I., Aston, C. E., Ferrell, R. E., & Hamman, R. F. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90129-i · Cited by 78 · see citing works
Nieminen, T. V. M., Kähönen, M. A. P., Viiri, L. E., Grönroos, P. E., & Lehtimäki, T. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.10.1475 · Cited by 77 · see citing works
- Authors
- Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B.
- Affiliations
- Tufts University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1986-09-01
- Volume
- 78
- Issue
- 3
- Pages
- 815-821
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC423680
- OpenAlex
- W1990170200
- Cited by
- 345
- References
- 27
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 8 · 2018: 7 · 2017: 6 · 2016: 6 · 2015: 3 · 2014: 4 · 2013: 9 · 2012: 8
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Keywords
- APOE ε4, apolipoprotein E3, APOE polymorphism, plasma residence time, VLDL, high-density lipoprotein, type V hyperlipoproteinemia, hypercholesterolemia, dyslipoproteinemia
- MeSH terms
- Adolescent, Adult, Apolipoproteins E, Female, Homozygote, Humans, Hypercholesterolemia, Hyperlipoproteinemia Type V, Iodine Radioisotopes, Kinetics, Lipoproteins, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Male, Phenotype, Apolipoprotein E3, Apolipoprotein E4, Lipoproteins, IDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review